Le Réseau Sciences et Développement
Actualités, opinions et informations sur la science, la technologie et les pays en développement
Nouvelles
Ethical violations in HPV vaccine trials, says committee
Source: The Hindu
20 mai 2011 | EN
An Indian official committee has found ethical violations in HPV vaccine trials in India.
Flickr/kelsey*
[NEW DELHI] An expert committee set up to investigate the conduct of studies using human papillomavirus (HPV) vaccines in India has reported large-scale ethical violations.
Members of the committee said since the project proposal involved research on human participants it should have followed "all the guidelines and statutory requirements applicable to research on human participants", the daily The Hindu reported.
"There has been direct contact with the human participants, they have administered an intervention which is not part of a prescribed prevention and have expected adverse events," members reported.
The committee comprised S.S. Aggarwal, former director of the Sanjay Gandhi Post-graduate Institute of Medical Sciences, S.P. Agarwal, former director-general of health services, and Suneeta Mittal, head of obstetrics and gynaecology at the All-India Institute of Medical Sciences (AIIMS) in New Delhi. They were assisted by a three-member sub-committee.
Members said there was a need for specific and separate legislation covering all aspects of biomedical and health research involving human participants and that statutory status should be given to the guidelines of the Indian Council of Medical Research.
AJOUTEZ VOTRE COMMENTAIRE
Patientez SVP
Tous les commentaires sont soumis à l’approbation de SciDev.Net et nous nous réservons le droit de modifier tout langage inapproprié ou malséant. SciDev.Net est propriétaire des droits d’auteur de toutes les ressources affichées sur son site Internet. Pour plus de détails, voir conditions d’utilisation.
Toutes les ressources de SciDev.Net peuvent être reproduites gratuitement, à condition que référence soit dûment faîte à la source et à l’auteur. Pour plus de détails, voir les licences Licences Creative Commons.
4 juin 2012